EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Advanced bispecific antibody design and inhaled biologics; emerging strategies for asthma

Zeina Kassem, Jenny K. W. Lam, Hanieh Khalili

RSC Pharmaceutics · 2026 · 3 (3) · 630-644

DOI: 10.1039/d5pm00230c ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Pharmaceutics, 2026. Verfasst von Zeina Kassem und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary delivery of inhalable bispecific antibodies for the localised treatment of asthma.

Zitieren

APA

Kassem, Z., Lam, J. K. W., & Khalili, H. (2026). Advanced bispecific antibody design and inhaled biologics; emerging strategies for asthma. RSC Pharmaceutics, 3(3), 630-644. https://doi.org/10.1039/d5pm00230c

Vancouver

Kassem Z, Lam JKW, Khalili H. Advanced bispecific antibody design and inhaled biologics; emerging strategies for asthma. RSC Pharmaceutics. 2026;3(3):630-644. doi:10.1039/d5pm00230c

BibTeX
@article{Kassem2026,
  author = {Kassem, Zeina and Lam, Jenny K. W. and Khalili, Hanieh},
  title = {Advanced bispecific antibody design and inhaled biologics; emerging strategies for asthma},
  journal = {RSC Pharmaceutics},
  year = {2026},
  volume = {3},
  number = {3},
  pages = {630--644},
  doi = {10.1039/d5pm00230c}
}
Kostenlos starten →